What is migraine? Controversy and stalemate in migraine pathophysiology J. Edmeads Review Of Migraine And Its Therapy Pages: S2 - S5
The clinical diagnosis of migraine: the beginning of therapy J. N. Blau Review Of Migraine And Its Therapy Pages: S6 - S11
Cerebral blood flow changes in migraine: methods, observations and hypotheses L. Friberg Review Of Migraine And Its Therapy Pages: S12 - S17
Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions M. A. MoskowitzM. G. Buzzi Review Of Migraine And Its Therapy Pages: S18 - S22
Pharmacology of antimigraine drugs P. R. SaxenaM. O. Den Boer Review Of Migraine And Its Therapy Pages: S28 - S35
5-HT in migraine — an introduction P. R. Saxena Migraine Therapy And 5-HT Receptor Activity Pages: S36 - S37
5-Hydroxytryptamine and the pathophysiology of migraine P. P. A. Humphrey Migraine Therapy And 5-HT Receptor Activity Pages: S38 - S44
5-HT2 receptor antagonists and migraine therapy E. J. Mylecharane Migraine Therapy And 5-HT Receptor Activity Pages: S45 - S52
5-HT3 receptor antagonists and migraine therapy M. D. Ferrari Migraine Therapy And 5-HT Receptor Activity Pages: S53 - S56
Rationale for the use of 5-HT1-like agonists in the treatment of migraine W. FeniukP. P. A. HumphreyE. T. Whalley Migraine Therapy And 5-HT Receptor Activity Pages: S57 - S61
Clinical experience with oral sumatriptan: a placebo-controlled, dose-ranging study J. P. Pattenthe Oral Sumatriptan Dose-defining Study Group Migraine Therapy And 5-HT Receptor Activity Pages: S62 - S65
Subcutaneous sumatriptan in the acute treatment of migraine F. B. M. Ensinkthe Sumatriptan International Study Group Migraine Therapy And 5-HT Receptor Activity Pages: S66 - S69